Huaren Pharmaceutical Co Ltd (300110) — Financial Flexibility Index
Huaren Pharmaceutical Co Ltd (300110) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of CN¥93.78 Million (operating CF CN¥86.78 Million minus capex CN¥7.00 Million) represents 0% of total liabilities (CN¥1.97 Billion). Check Huaren Pharmaceutical Co Ltd (300110) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Huaren Pharmaceutical Co Ltd Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Huaren Pharmaceutical Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see 300110 cash flow metrics.
Annual Financial Flexibility Index for Huaren Pharmaceutical Co Ltd (2007–2025)
Year-by-year free cash flow to debt coverage for Huaren Pharmaceutical Co Ltd. Explore 300110 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.24x | CN¥439.21 Million | CN¥390.23 Million | CN¥1.79 Billion | ▲ +45.0% |
| 2024 | 0.17x | CN¥347.05 Million | CN¥322.36 Million | CN¥2.05 Billion | ▲ +15.4% |
| 2023 | 0.15x | CN¥351.46 Million | CN¥305.60 Million | CN¥2.40 Billion | ▲ +44.2% |
| 2022 | 0.10x | CN¥260.31 Million | CN¥217.98 Million | CN¥2.56 Billion | ▲ +159.0% |
| 2021 | -0.17x | CN¥-550.66 Million | CN¥-578.52 Million | CN¥3.20 Billion | ▼ -496.0% |
| 2020 | 0.04x | CN¥47.22 Million | CN¥-10.74 Million | CN¥1.09 Billion | ▼ -94.1% |
| 2019 | 0.74x | CN¥341.35 Million | CN¥309.33 Million | CN¥461.81 Million | ▲ +121.2% |
| 2018 | 0.33x | CN¥299.79 Million | CN¥254.32 Million | CN¥897.11 Million | ▲ +49.9% |
| 2017 | 0.22x | CN¥298.44 Million | CN¥211.08 Million | CN¥1.34 Billion | ▼ -23.8% |
| 2016 | 0.29x | CN¥350.60 Million | CN¥181.65 Million | CN¥1.20 Billion | ▲ +118.1% |
| 2015 | 0.13x | CN¥175.50 Million | CN¥18.77 Million | CN¥1.31 Billion | ▼ -52.9% |
| 2014 | 0.28x | CN¥325.36 Million | CN¥65.56 Million | CN¥1.14 Billion | ▼ -3.3% |
| 2013 | 0.29x | CN¥267.47 Million | CN¥39.78 Million | CN¥907.56 Million | ▼ -64.5% |
| 2012 | 0.83x | CN¥369.87 Million | CN¥99.44 Million | CN¥445.69 Million | ▼ -84.2% |
| 2011 | 5.24x | CN¥292.36 Million | CN¥59.53 Million | CN¥55.77 Million | ▲ +72.4% |
| 2010 | 3.04x | CN¥144.71 Million | CN¥77.61 Million | CN¥47.60 Million | ▲ +620.5% |
| 2009 | 0.42x | CN¥135.87 Million | CN¥38.63 Million | CN¥321.98 Million | ▼ -35.8% |
| 2008 | 0.66x | CN¥188.07 Million | CN¥57.24 Million | CN¥286.30 Million | ▲ +606.0% |
| 2007 | 0.09x | CN¥16.52 Million | CN¥7.66 Million | CN¥177.50 Million | — |